Accretion Pharmaceuticals Ltd vs Asston Pharmaceuticals Ltd Stock Comparison
Accretion Pharmaceuticals Ltd vs Asston Pharmaceuticals Ltd Stock Comparison
Last Updated on: May 12, 2026
Key Highlights
The Latest Trading Price of Accretion Pharmaceuticals Ltd is ₹ 122.25 as of 12 May 15:30
. The P/E Ratio of Accretion Pharmaceuticals Ltd changed from 0 on March 2024 to 0 on March 2023 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Asston Pharmaceuticals Ltd changed from 0 on March 2024 to 0 on March 2023 . This represents a CAGR of 0.0% over 4 years The Market Cap of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Asston Pharmaceuticals Ltd changed from ₹ 0 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of 0.0% over 4 years The Dividend Payout of Accretion Pharmaceuticals Ltd changed from 0 % on March 2024 to 0 % on March 2023 . This represents a CAGR of 0.0% over 4 yearsThe Dividend Payout of Asston Pharmaceuticals Ltd changed from 0 % on March 2024 to 0 % on March 2023 . This represents a CAGR of 0.0% over 4 years .
About Accretion Pharmaceuticals Ltd
Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products.
Thus, the foundation of 'Accretion Pharmaceuticals' was laid down, which was started as a Partnership Firm in the name of 'M/s Accretion Pharmaceuticals', pursuant to a deed of partnership dated December 18, 2012.
The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in 2014.
Thereafter, the Partnership Firm was converted into a Limited Company in the name of 'Accretion Pharmaceuticals Limited' and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.
About Asston Pharmaceuticals Ltd
Asston Pharmaceuticals Limited was incorporated on 16th April 2019 as 'Asston Pharmaceutical Pvt.
Limited' to contract produce pharmaceutical products for export market.
Later on 1st April 2024, Company acquired Ferron Lifecare Private Limited, specializing into nutraceuticals business and produced nutraceutical products at their Ambarnath facility.
Ferron Lifecare Private Limited, incorporated on 30th January 2020.
Finally, 'Asston Pharmaceuticals Private Limited' was converted into a Public Limited Company in the name of 'Asston Pharmaceuticals Limited' on 29th August 2024 and received FDA approval for its Ambarnath facility on 2nd December 2024 to produce pharmaceutical products.
Presently, Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion) and Oral Powder (Sachet, Dry Syrup) etc.
FAQs for the comparison of Accretion Pharmaceuticals Ltd and Asston Pharmaceuticals Ltd
Which company has a larger market capitalization, Accretion Pharmaceuticals Ltd or Asston Pharmaceuticals Ltd?
Market cap of Accretion Pharmaceuticals Ltd is 135 Cr while Market cap of Asston Pharmaceuticals Ltd is 67 Cr
What are the key factors driving the stock performance of Accretion Pharmaceuticals Ltd and Asston Pharmaceuticals Ltd?
The stock performance of Accretion Pharmaceuticals Ltd and Asston Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Accretion Pharmaceuticals Ltd and Asston Pharmaceuticals Ltd?
As of May 12, 2026, the Accretion Pharmaceuticals Ltd stock price is INR ₹122.25. On the other hand, Asston Pharmaceuticals Ltd stock price is INR ₹79.0.
How do dividend payouts of Accretion Pharmaceuticals Ltd and Asston Pharmaceuticals Ltd compare?
To compare the dividend payouts of Accretion Pharmaceuticals Ltd and Asston Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.